APA (7th ed.) Citation

AS, P., EL, S., EC, S., MJ, C., PD, A., A, P., . . . TV, N. (2026). Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis. American journal of clinical dermatology, 27(3), 611. https://doi.org/10.1007/s40257-026-01018-1

Chicago Style (17th ed.) Citation

AS, Paller, et al. "Safety and Efficacy of Treatment with Dupilumab for Up to 2 Years in Infants and Young Children with Atopic Dermatitis." American Journal of Clinical Dermatology 27, no. 3 (2026): 611. https://doi.org/10.1007/s40257-026-01018-1.

MLA (9th ed.) Citation

AS, Paller, et al. "Safety and Efficacy of Treatment with Dupilumab for Up to 2 Years in Infants and Young Children with Atopic Dermatitis." American Journal of Clinical Dermatology, vol. 27, no. 3, 2026, p. 611, https://doi.org/10.1007/s40257-026-01018-1.